Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Consensus Recommendations – Locoregional Melanoma

ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee

Published in 2020 – Ann Oncol (2020)
Authors: O. Michielin, P. A. Ascierto, R. Dummer, C. Robert, P. Lorigan, A. van Akkooi, A. Arance, C.U. Blank, V. Chiarion Sileni, M. Donia, M.B. Faries, C. Gaudy-Marqueste, H. Gogas, J.J. Grob, M. Guckenberger, J. Haanen, A.J. Hayes, C. Hoeller, C. Lebbé, I. Lugowska, M. Mandalà, I. Márquez-Rodas, P. Nathan, B. Neyns, R. Olofsson Bagge, S. Puig, P. Rutkowski, B. Schilling, V.K. Sondak, H. Tawbi, A. Testori & U. Keilholz

The ESMO consensus conference manuscript on locoregional melanoma was compiled by a multidisciplinary panel of experts and compiles recommendations with supporting evidence on controversial topics in melanoma management. Recommendations for locoregional melanoma in this manuscript include indications for SLNB and RLND, adjuvant targeted versus immunotherapy, adjuvant therapy in specific situations and adjuvant therapy toxicity management.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings